Like oil, data needs to be found and extracted, cleaned and refined, then transported to its destination.
Real-world evidence is seen by many as a key fuel to power pharma’s next evolution – from a drug developer/seller to an end-to-end healthcare solutions provider – but pharma still faces many challenges along the way.
In eyeforpharma’s latest Trends in Real-World Evidence Magazine, we feature articles that explore how to manage these challenges.
Download the latest free magazine here: https://bit.ly/2KR7jKF
Hear key insights from:
- Joseph Dye, Head of HEOR, Neurology US, UCB
- Sean McElligott, Director, Global Market Access Lead Dermatology, Janssen
- Michelle Hoiseth, Corporate VP, Parexel International
- Aaron Mitchell, Managing Principal and Global Lead for R&D Excellence Practice, ZS
- Merat Baghaformer, Director of Marketing, Digital Health & Patient Care, Merck
- Sajan Khosla, Head of Real World Evidence – Center of Excellence, AZ
Read the full free magazine here: https://bit.ly/2KR7jKF